← Back to Search

Non-invasive Brain Stimulation

Temporal Lobe Epilepsy Patients for Epilepsy

N/A

Waitlist Available

Led By Anli Liu, MD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately before motor cortex stimulation, immediately after motor cortex stimulation (20 minute procedure; up to week 6)

Awards & highlights

Study Summary

This trialwill study whether epilepsy patients benefit from TMS interventions as much as healthy controls, and look at the effects on brain connectivity.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately before motor cortex stimulation, immediately after motor cortex stimulation (20 minute procedure; up to week 6)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately before motor cortex stimulation, immediately after motor cortex stimulation (20 minute procedure; up to week 6)

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately before motor cortex stimulation, immediately after motor cortex stimulation (20 minute procedure; up to week 6) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean Change in Face-Object Pair Association Task Score during Left Lateral Parietal Site Stimulation

Mean Change in Face-Object Pair Association Task Score during Motor Cortex Stimulation

Secondary outcome measures

Change in fMRI-based Functional Connectivity between Hippocampus and Cortical Regions

Mean Change in Word-Pair Association Task Score during Left Lateral Parietal Site Stimulation

Mean Change in Word-Pair Association Task Score during Motor Cortex Stimulation

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Temporal Lobe Epilepsy PatientsExperimental Treatment1 Intervention

Group II: Healthy SubjectsActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MagStim RapidStim2

2016

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,367 Previous Clinical Trials

839,759 Total Patients Enrolled

25 Trials studying Epilepsy

3,041 Patients Enrolled for Epilepsy

Anli Liu, MDPrincipal InvestigatorNew York University Medical School

4 Previous Clinical Trials

11 Total Patients Enrolled

4 Trials studying Epilepsy

11 Patients Enrolled for Epilepsy

Media Library

Repetitive Transcranial Magnetic Stimulation (TMS) (Non-invasive Brain Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT02749422 — N/A

Epilepsy Research Study Groups: Temporal Lobe Epilepsy Patients, Healthy Subjects

Epilepsy Clinical Trial 2023: Repetitive Transcranial Magnetic Stimulation (TMS) Highlights & Side Effects. Trial Name: NCT02749422 — N/A

Repetitive Transcranial Magnetic Stimulation (TMS) (Non-invasive Brain Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02749422 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical study accepting new participants?

"According to clinicaltrials.gov's records, the study is no longer accepting applicants; it was first posted on October 14th 2016 and last updated on October 12th 2022. Nevertheless, 239 other medical studies are still searching for patients at this time."

Answered by AI

Who qualifies for inclusion in this medical experiment?

"Eligible participants must present with aura and be between the ages of 18 to 40. This medical study is aiming to include 8 patients in total."

Answered by AI

Is the age threshold for inclusion in this research over 80 years old?

"This trial requires participants to be aged 18-40; however, there are 103 trials with age restrictions below 18 and 156 clinical studies for patients beyond the retirement age."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

fMRI Guided TMS Enhancement of Associative Memory Networks

2016. "fMRI Guided TMS Enhancement of Associative Memory Networks". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02749422.